Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
181
Employees181
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
181
Employees181

AKBA Key Statistics

Market cap
780.85M
Market cap780.85M
Price-Earnings ratio
-17.25
Price-Earnings ratio-17.25
Dividend yield
Dividend yield
Average volume
3.96M
Average volume3.96M
High today
$3.00
High today$3.00
Low today
$2.91
Low today$2.91
Open price
$2.99
Open price$2.99
Volume
2.24M
Volume2.24M
52 Week high
$4.08
52 Week high$4.08
52 Week low
$1.24
52 Week low$1.24

AKBA News

Simply Wall St 1d
Retail investors who have a significant stake must be disappointed along with institutions after Akebia Therapeutics, Inc.'s market cap dropped by US$50m

Advertisement Key Insights The considerable ownership by retail investors in Akebia Therapeutics indicates that they collectively have a greater say in manage...

Retail investors who have a significant stake must be disappointed along with institutions after Akebia Therapeutics, Inc.'s market cap dropped by US$50m

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.